07:37 AM EST, 02/18/2025 (MT Newswires) -- NeoGenomics ( NEO ) reported Tuesday Q4 adjusted earnings of $0.04 per diluted share, up from $0.03 a year earlier.

Analysts polled by FactSet expected $0.03.

Net revenue for the quarter ended Dec. 31 was $172 million, up from $155.6 million a year earlier.

Analysts surveyed by FactSet expected $173.2 million.

For 2025, the company expects adjusted diluted EPS of $0.15 to $0.19. Analysts surveyed by FactSet expect $0.20.

The company expects 2025 consolidated revenue of $735 million to $745 million. Analysts polled by FactSet expect $733.1 million.

Shares were down nearly 8% in premarket activity.